Items Tagged ‘pictilisib’

March 5th, 2015

The Novel Small Molecule Pictilisib May Benefit Women with Advanced Breast Cancer


The addition of the investigational drug pictilisib to Faslodex® (fulvestrant) has been demonstrated to delay the time of cancer in women with advanced or metastatic breast cancer to be positive for both estrogen receptor (ER) and progesterone receptor (PR) who have previously failed treatment with an aromatase inhibitor. Each year roughly 200,000 U.S. women are […]

View full entry

Tags: Breast Cancer, Faslodex, fulvestrant, hormone-receptor positive, Metastatic Breast Cancer, News, pictilisib, Recurrent Breast Cancer